RF GP Ablation Added to PEF PVI for Paroxysmal AF
Key facts
- Who runs it
- Institute for Clinical and Experimental Medicine
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 250 people, planned
- Starts
- 1 Apr 2027
- Expected to end
- 1 Apr 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- pulmonary vein isolation and roof line ablation
- GP ablation
- Record updated
- 17 November 2026
Who can take part
- Age
- 30 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Patients with drug-resistant symptomatic paroxysmal AF meeting all the following criteria:; Paroxysmal AF that terminates spontaneously or with intervention within 7 days of onset; Failed AAD treatment, defined as ineffective, intolerant or inappropriate ≥1 Class I-IV AAD
- Patients who are ≥30 and ≤65 years of age on the day of enrolment
- Patients who are willing and capable of:; Providing informed consent to undergo study procedures AND; Participating in all examinations, follow-up visits, and tests associated with this clinical study
- Effective contraception for women of childbearing potential
- Effective oral anticoagulation for >3 weeks before the planned ablation procedure
Who cannot take part
- Any prior atrial endocardial or epicardial ablation procedure, including cavotricuspid isthmus (CTI) ablation or right-sided AT
- Any prior atrial surgery
- AF secondary to electrolyte imbalance, thyroid disease, alcohol, or other reversible / non-cardiac causes
- Autonomic dysfunction, e.g., cardiac autonomic neuropathy due to diabetes mellitus
- Left ventricular ejection fraction <40%
- Persistent, long-standing persistent, or permanent AF
- Left atrial (LA) anteroposterior diameter ≥50 mm (by transthoracic echocardiography)
- Intra-atrial septal patch or interatrial shunt
- General contraindications of catheter ablation
- LA appendage closure, device, or occlusion, past or anticipated
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 30 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will investigate whether adjunctive RF GP ablation, when added to PF PVI, improves freedom from AF or atrial tachycardia (AT). By directly addressing the potential limitation of autonomic modulation associated with PF ablation alone, this study will provide mechanistic and clinically relevant insights into the role of parasympathetic modulation of the heart in preventing AF recurrence.
Read full original descriptionShow less
The results are expected to yield novel, clinically meaningful evidence that may help refine and optimize catheter ablation workflows, particularly in the era of non-thermal energy sources.
The 2 groups in the trial
- RF GP + PEF PVITreatment being tested
Radiofrequency ablation of ganglionated plexi added to pulmonary vein isolation and roof line ablation using pulsed electric field
Treatment: pulmonary vein isolation and roof line ablation and GP ablation
- PEF PVIExisting treatment, for comparison
Pulmonary vein isolation and roof line ablation using pulsed electric field energy
Treatment: pulmonary vein isolation and roof line ablation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- RadiofrEquency Ablation of Ganglionated Plexi Added to The Pulsed ElecTric Field Pulmonary Vein Isolation for PAroxysmal Atrial Fibrillation (REGATTA-AF Study)
- Criteria questions
- Built from NCT07943013, who can take part
- Record updated
- 17 November 2026